Release Date: 16/08/16 12:38 Summary: Appendix 4G and Corporate Governance Statement-OTC.AX Price Sensitive: No Download Document 774.76KB Download
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status